Masin Jiri, Basler Marek, Knapp Oliver, El-Azami-El-Idrissi Mohammed, Maier Elke, Konopasek Ivo, Benz Roland, Leclerc Claude, Sebo Peter
Institute of Microbiology, Academy of Sciences of the Czech Republic, 142 20, Prague 4, Czech Republic.
Biochemistry. 2005 Sep 27;44(38):12759-66. doi: 10.1021/bi050459b.
The Bordetella adenylate cyclase toxin-hemolysin (CyaA, ACT, or AC-Hly) forms cation-selective membrane channels and delivers into the cytosol of target cells an adenylate cyclase domain (AC) that catalyzes uncontrolled conversion of cellular ATP to cAMP. Both toxin activities were previously shown to depend on post-translational activation of proCyaA to CyaA by covalent palmitoylation of the internal Lys983 residue (K983). CyaA, however, harbors a second RTX acylation site at residue Lys860 (K860), and the role of K860 acylation in toxin activity is unclear. We produced in E. coli the CyaA-K860R and CyaA-K983R toxin variants having the Lys860 and Lys983 acylation sites individually ablated by arginine substitutions. When examined for capacity to form membrane channels and to penetrate sheep erythrocytes, the CyaA-K860R acylated on Lys983 was about 1 order of magnitude more active than CyaA-K983R acylated on Lys860, although, in comparison to intact CyaA, both monoacylated constructs exhibited markedly reduced activities in erythrocytes. Channels formed in lipid bilayers by CyaA-K983R were importantly less selective for cations than channels formed by CyaA-K860R, intact CyaA, or proCyaA, showing that, independent of its acylation status, the Lys983 residue may play a role in toxin structures that determine the distribution of charged residues at the entry or inside of the CyaA channel. While necessary for activity on erythrocytes, acylation of Lys983 was also sufficient for the full activity of CyaA on CD11b+ J774A.1 monocytes. In turn, acylation of Lys860 alone did not permit toxin activity on erythrocytes, while it fully supported the high-affinity binding of CyaA-K983R to the toxin receptor CD11b/CD18 and conferred on CyaA-K983R a reduced but substantial capacity to penetrate and kill the CD11b+ cells. This is the first evidence that acylation of Lys860 may play a role in the biological activity of CyaA, even if redundant to the acylation of Lys983.
博德特氏菌腺苷酸环化酶毒素 - 溶血素(CyaA、ACT或AC - Hly)可形成阳离子选择性膜通道,并将一个腺苷酸环化酶结构域(AC)递送至靶细胞的胞质溶胶中,该结构域可催化细胞内ATP不受控制地转化为cAMP。先前已表明,这两种毒素活性均依赖于通过内部赖氨酸983残基(K983)的共价棕榈酰化将前体CyaA翻译后激活为CyaA。然而,CyaA在赖氨酸860残基(K860)处还有第二个RTX酰化位点,K860酰化在毒素活性中的作用尚不清楚。我们在大肠杆菌中产生了CyaA - K860R和CyaA - K983R毒素变体,其中赖氨酸860和赖氨酸983酰化位点分别被精氨酸取代而消除。当检测它们形成膜通道和穿透绵羊红细胞的能力时,在赖氨酸983处被酰化的CyaA - K860R比在赖氨酸860处被酰化的CyaA - K983R活性高约1个数量级,尽管与完整的CyaA相比,两种单酰化构建体在红细胞中的活性均显著降低。CyaA - K983R在脂质双层中形成的通道对阳离子的选择性明显低于CyaA - K860R、完整的CyaA或前体CyaA形成的通道,这表明,无论其酰化状态如何,赖氨酸983残基可能在决定CyaA通道入口或内部带电残基分布的毒素结构中发挥作用。虽然赖氨酸983的酰化对于在红细胞上的活性是必需的,但它对于CyaA在CD11b + J774A.1单核细胞上的完全活性也是足够的。反过来,仅赖氨酸860的酰化不允许毒素在红细胞上具有活性,而它完全支持CyaA - K983R与毒素受体CD11b / CD18的高亲和力结合,并赋予CyaA - K983R降低但相当大的穿透和杀死CD11b +细胞的能力。这是第一个证据表明赖氨酸860的酰化可能在CyaA的生物学活性中发挥作用,即使相对于赖氨酸983的酰化是多余的。